# Cenntro Inc.: overview CENN · Nasdaq · CIK 1707919 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cenn.md) · [Financials](/companies/cenn/financials.md) · [Filings](/companies/cenn/filings.md) · [Insiders](/companies/cenn/insiders.md) Latest reported revenue: [$6.2m](/filings/0001140361-26-033166.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001140361-26-033166). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [16.2](/filings/0001140361-25-041657.md) | [5.4 d](/filings/0001140361-26-014773.md) | [2.1](/filings/0001140361-26-021332.md) | [6.4](/filings/0001140361-26-033166.md) | [4.6](/filings/0001140361-25-041657.md) | [5.0 d](/filings/0001140361-26-014773.md) | [1.2](/filings/0001140361-26-021332.md) | [6.2](/filings/0001140361-26-033166.md) | | Gross margin | % | [38.8%](/filings/0001140361-25-041657.md) | [(8.1%) d](/filings/0001140361-26-014773.md) | [15.0%](/filings/0001140361-26-021332.md) | [(0.3%)](/filings/0001140361-26-033166.md) | [2.3%](/filings/0001140361-25-041657.md) | [(54.9%) d](/filings/0001140361-26-014773.md) | [19.6%](/filings/0001140361-26-021332.md) | [6.6%](/filings/0001140361-26-033166.md) | | Operating margin | % | [(40.4%)](/filings/0001140361-25-041657.md) | [(190.2%) d](/filings/0001140361-26-014773.md) | [(288.1%)](/filings/0001140361-26-021332.md) | [(126.4%)](/filings/0001140361-26-033166.md) | [(150.4%)](/filings/0001140361-25-041657.md) | [(229.9%) d](/filings/0001140361-26-014773.md) | [(328.4%)](/filings/0001140361-26-021332.md) | [(120.5%)](/filings/0001140361-26-033166.md) | | Net margin | % | [(55.3%)](/filings/0001140361-25-041657.md) | [(323.2%) d](/filings/0001140361-26-014773.md) | [(263.8%)](/filings/0001140361-26-021332.md) | [(154.4%)](/filings/0001140361-26-033166.md) | [(146.7%)](/filings/0001140361-25-041657.md) | [(1022.8%) d](/filings/0001140361-26-014773.md) | [(322.4%)](/filings/0001140361-26-021332.md) | [(169.9%)](/filings/0001140361-26-033166.md) | | Diluted EPS | $ per share | [(0.29)](/filings/0001140361-25-041657.md) | not reported | [(10.99)](/filings/0001140361-26-021332.md) | [(16.30)](/filings/0001140361-26-033166.md) | [(0.14)](/filings/0001140361-25-041657.md) | not reported | [(2.66)](/filings/0001140361-26-021332.md) | [(5.97)](/filings/0001140361-26-033166.md) | | Free cash flow | $m | [(0.3) d](/filings/0001140361-25-041657.md) | [(8.6) d](/filings/0001140361-26-014773.md) | [(5.5)](/filings/0001140361-26-021332.md) | [(4.5) d](/filings/0001140361-26-033166.md) | [(1.5) d](/filings/0001140361-25-041657.md) | not reported | [(2.8)](/filings/0001140361-26-021332.md) | [(2.8) d](/filings/0001140361-26-033166.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [8.6](/filings/0001140361-23-033413.md) | [8.9](/filings/0001140361-24-016853.md) | [10.4](/filings/0001140361-25-011607.md) | [31.3](/filings/0001140361-26-014773.md) | [18.1](/filings/0001140361-26-014773.md) | | Gross margin | % | [17.5%](/filings/0001140361-23-033413.md) | [(5.7%)](/filings/0001140361-24-016853.md) | [15.5%](/filings/0001140361-25-011607.md) | [24.3%](/filings/0001140361-26-014773.md) | [(12.8%)](/filings/0001140361-26-014773.md) | | Operating margin | % | [(191.9%)](/filings/0001140361-23-033413.md) | [(617.7%)](/filings/0001140361-24-016853.md) | [(414.8%)](/filings/0001140361-25-011607.md) | [(101.7%)](/filings/0001140361-26-014773.md) | [(180.0%)](/filings/0001140361-26-014773.md) | | Net margin | % | [(191.5%)](/filings/0001140361-23-033413.md) | [(1231.2%)](/filings/0001140361-24-016853.md) | [(519.9%)](/filings/0001140361-25-011607.md) | [(143.4%)](/filings/0001140361-26-014773.md) | [(403.7%)](/filings/0001140361-26-014773.md) | | Diluted EPS | $ per share | [(0.09)](/filings/0001140361-23-033413.md) | [(4.18)](/filings/0001140361-24-016853.md) | [(1.78)](/filings/0001140361-25-011607.md) | [(87.28)](/filings/0001140361-26-014773.md) | [(87.21)](/filings/0001140361-26-014773.md) | | Free cash flow | $m | [(22.2)](/filings/0001140361-23-033413.md) | [(72.7)](/filings/0001140361-24-016853.md) | [(66.1)](/filings/0001140361-25-011607.md) | [(22.2)](/filings/0001140361-26-014773.md) | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cenn/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $81.9k | 23,015 | | New +23,015 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $74.5k | 20,916 | | New +20,916 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $56.5k | 15,867 | | New +15,867 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $22.7k | 6,387 | | New +6,387 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $15.9k | 4,453 | | New +4,453 | | [CITIGROUP INC](/funds/831001.md) | 2026-06-30 | $8.5k | 2,401 | | New +2,401 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $4.1k | 1,153 | | New +1,153 | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $234 | 67 | | New +67 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $50 | 14 | | New +14 | | [BNP PARIBAS FINANCIAL MARKETS](/funds/1166588.md) | 2026-06-30 | $28 | 8 | | New +8 | ## Recent filings [All 343 filings](/companies/cenn/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-21 | 01:49 ET | [8-K/A](/filings/0001140361-26-040307.md) | 9.01 Financial statements and exhibits | 0001140361-26-040307 | | 2026-10-15 | 21:16 ET | [8-K](/filings/0001140361-26-039778.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-039778 | | 2026-09-17 | 01:47 ET | [8-K](/filings/0001140361-26-036815.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-26-036815 | | 2026-08-31 | 20:30 ET | [8-K](/filings/0001140361-26-035085.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-26-035085 | | 2026-08-14 | 20:33 ET | [10-Q](/filings/0001140361-26-033166.md) | Quarterly report, period 2026-06-30 | 0001140361-26-033166 | | 2026-07-28 | 21:15 ET | [8-K](/filings/0001140361-26-029905.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-26-029905 | | 2026-06-05 | 20:04 ET | [8-K](/filings/0001140361-26-024261.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-26-024261 | | 2026-05-20 | 21:16 ET | [8-K](/filings/0001140361-26-022277.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-26-022277 | | 2026-05-14 | 20:31 ET | [10-Q](/filings/0001140361-26-021332.md) | Quarterly report, period 2026-03-31 | 0001140361-26-021332 | | 2026-05-01 | 20:01 ET | [8-K](/filings/0001140361-26-018535.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-018535 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001140361-26-014773.md), filed Apr 15, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/4bc323f5-4f07-4544-a348-b333c558056f) ## About the filer - CIK: 1707919 - Tickers: CENN - Exchange: Nasdaq - SIC code: 3711 Motor Vehicles & Passenger Car Bodies - State of incorporation: NV - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.